Unkind Cuts in Canada

OTTAWA-The National Research Council managed to dampen the celebration of Canadian John Polanyi's Nobel Prize in chemistry last month by announcing on the same day that it was eliminating the section where he did his re search as part of widespread cuts in science funding. The Council said it would save $20 million by eliminating 200 positions and dozens of programs. (The Canadian dollar is worth 72 cents U.S.) About $12 million will be diverted to Canada's space program, to support its communic

Written byDavid Spurgeon
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

OTTAWA-The National Research Council managed to dampen the celebration of Canadian John Polanyi's Nobel Prize in chemistry last month by announcing on the same day that it was eliminating the section where he did his re search as part of widespread cuts in science funding.

The Council said it would save $20 million by eliminating 200 positions and dozens of programs. (The Canadian dollar is worth 72 cents U.S.) About $12 million will be diverted to Canada's space program, to support its communications satellites and other applied projects. The rest will contribute to shrinking the country's $34 billion budget deficit. The cuts include the photochemistry and kinetics section at the University of Toronto, where Polanyi laid the groundwork in the late 1950s for the development of the chemical laser with his work on molecular reactions.

"It's an unfortunate coincidence," acknowledged Ross Pottie, a senior vice president of laboratories for the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies